{"ModuleTitle": "Company Description", "CompanyName": "ADMA Biologics Inc", "Symbol": "ADMA", "Address": "C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17, RAMSEY, New Jersey, 07446, United States of America", "Phone": "(201) 478-5552", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Unless the context otherwise requires, references in this Business section to\r\n\"ADMA,\" \"ADMA Biologics,\" the \"Company,\" \"we,\" \"us\" and \"our\" refer to ADMA\r\nBiologics, Inc., a Delaware corporation, as well as its wholly-owned and\r\nindirectly-owned subsidiaries, ADMA Plasma Biologics, Inc., a Delaware\r\ncorporation, ADMA Bio Centers Georgia Inc., a Delaware corporation (\"ADMA Bio\r\nCenters\") and ADMA BioManufacturing, LLC, a Delaware limited liability company\r\n(\"ADMA BioManufacturing\").\r\n\r\n \r\n\r\nOverview\r\n\r\n \r\n\r\nWe are an end-to-end commercial biopharmaceutical company dedicated to\r\nmanufacturing, marketing and developing specialty plasma-derived biologics for\r\nthe treatment of immunodeficient patients at risk for infection and others at\r\nrisk for certain infectious diseases. Our targeted patient populations include\r\nimmune-compromised individuals who suffer from an underlying immune deficiency\r\ndisorder or who may be immune-suppressed for medical reasons.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f13%2f0001193805-20-000348.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Adam S. Grossman", "title": "President, Chief Executive Officer & Director"}, {"name": "Brian Lenz", "title": "Executive VP, Chief Financial & Accounting Officer"}, {"name": "James Mond", "title": "Executive VP, Chief Scientific & Medical Officer"}, {"name": "Kaitlin Kestenberg", "title": "Vice President-Compliance & Clinical Operations"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}